UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tissue invasion and metastasis: Molecular, biological and clinical perspectives

Seminars in cancer biology, 2015-12, Vol.35, p.S244-S275

2015

Volltextzugriff (PDF)

Prognostic relevance of topoisomerase II [alpha] and minichromosome maintenance protein 6 expression in colorectal cancer

BMC cancer, 2019-05, Vol.19 (1)

2019

Volltextzugriff (PDF)

The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors

Current cancer drug targets, 2011-05, Vol.11 (4), p.524-535

2011

Volltextzugriff (PDF)

Changes over time in the course of advanced pancreatic cancer treatment with systemic chemotherapy: a pooled analysis of five clinical trials from two decades of the German AIO study group

ESMO open, 2024-04, Vol.9 (4), p.102944, Article 102944

2024

Volltextzugriff (PDF)

Randomized Phase III Study of Gemcitabine and Vinorelbine Versus Gemcitabine, Vinorelbine, and Cisplatin in the Treatment of Advanced Non-Small-Cell Lung Cancer: From the German and Swiss Lung Cancer Study Group

Journal of clinical oncology, 2004-06, Vol.22 (12), p.2348-2356

2004

Volltextzugriff (PDF)

Standardprozesse ambulanter psychosozialer Krebsberatung: Ein Beitrag der Landeskrebsgesellschaften zur Qualitätssicherung des Beratungsprozesses

Forum (Heidelberg), 2019-12, Vol.34 (6), p.527-536

2019

Volltextzugriff (PDF)

Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines

Leukemia, 1999-11, Vol.13 (11), p.1864-1872

1999

Volltextzugriff (PDF)

Molecular effects of topoisomerase II inhibitors in AML cell lines: correlation of apoptosis with topoisomerase II activity but not with DNA damage

Leukemia, 1999-11, Vol.13 (11), p.1859-1863

1999

Volltextzugriff (PDF)

Culprit and victim – DNA topoisomerase II

The lancet oncology, 2002-04, Vol.3 (4), p.235-243

2002

Volltextzugriff (PDF)

Cellular resistance mechanisms with impact on the therapy of multiple myeloma

Leukemia, 1997-12, Vol.11 Suppl 5, p.S1

1997

Volltextzugriff (PDF)

Cellular resistance mechanisms with impact on the therapy of multiple myeloma

Leukemia, 1998-07, Vol.12 (7), p.1009-1012

1998

Volltextzugriff (PDF)

P-glycoprotein expression in patients with acute leukemia : Clinical relevance

Leukemia, 1996-07, Vol.10, p.S23-S31

1996

Volltextzugriff (PDF)

Commutators of PAR-1 signaling in cancer cell invasion reveal an essential role of the Rho-Rho kinase axis and tumor microenvironment

Oncogene, 2005-12, Vol.24 (56), p.8240-8251

2005

Volltextzugriff (PDF)

Topoisomerase II activities in AML blasts and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines

Leukemia, 1996, Vol.10 (7), p.1177-1180

1996

Volltextzugriff (PDF)

Oral idarubicin, dexamethasone and vincristine (VID) in the treatment of multiple myeloma

Leukemia, 1997-12, Vol.11 Suppl 5, p.S22

1997

Volltextzugriff (PDF)

Functional P-gp expression in multiple myeloma patients at primary diagnosis and relapse or progressive disease

Leukemia, 1997-12, Vol.11 Suppl 5, p.S10-S14

1997

Volltextzugriff (PDF)

Topoisomerase II activities in AML blasts and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines

Leukemia, 1996-07, Vol.10, p.S46-S49

1996

Volltextzugriff (PDF)

In Vitro Efficacy of Known P-Glycoprotein Modulators Compared to Droloxifene E and Z: Studies on a Human T-Cell Leukemia Cell Line and their Resistant Variants

Leukemia & lymphoma, 1998, Vol.31 (5-6), p.589-597

1998

Volltextzugriff (PDF)

Nuclear Topoisomerase II Activity Changes During HL-60 Leukemic Cell Differentiation: Alterations in Drug Sensitivity and pH Dependency

Leukemia & lymphoma, 1991, Vol.5 (4), p.273-279

1991

Volltextzugriff (PDF)

Designing a broad-spectrum integrative approach for cancer prevention and treatment

Seminars in cancer biology, 2015-12, Vol.35, p.S276-S304

2015

Volltextzugriff (PDF)

Uncoupling of EGFR-RAS signaling and nuclear localization of YBX1 in colorectal cancer

Oncogenesis (New York, NY), 2016-01, Vol.5 (1), p.e187-e187

2016

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(21)

Sprache

Englisch
(20)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Humans
(15)
Hematology
(12)
Biological And Medical Sciences
(6)
Medical Sciences
(6)
Chemotherapy
(5)
Middle Aged
(5)
Aged
(4)
Antineoplastic Agents
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Apoptosis
(4)
Drug Resistance, Neoplasm
(4)
Gene Expression
(4)
Multiple Myeloma - Drug Therapy
(4)
P-Glycoprotein
(4)
Pharmacology. Drug Treatments
(4)
Proteins
(4)
Acute Myeloid Leukemia
(3)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tissue invasion and metastasis: Molecular, biological and clinical perspectives

Prognostic relevance of topoisomerase II [alpha] and minichromosome maintenance protein 6 expression in colorectal cancer

The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors

Changes over time in the course of advanced pancreatic cancer treatment with systemic chemotherapy: a pooled analysis of five clinical trials from two decades of the German AIO study group

Randomized Phase III Study of Gemcitabine and Vinorelbine Versus Gemcitabine, Vinorelbine, and Cisplatin in the Treatment of Advanced Non-Small-Cell Lung Cancer: From the German and Swiss Lung Cancer Study Group

Standardprozesse ambulanter psychosozialer Krebsberatung: Ein Beitrag der Landeskrebsgesellschaften zur Qualitätssicherung des Beratungsprozesses

Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines

Molecular effects of topoisomerase II inhibitors in AML cell lines: correlation of apoptosis with topoisomerase II activity but not with DNA damage

Culprit and victim – DNA topoisomerase II

Cellular resistance mechanisms with impact on the therapy of multiple myeloma

Cellular resistance mechanisms with impact on the therapy of multiple myeloma

P-glycoprotein expression in patients with acute leukemia : Clinical relevance

Commutators of PAR-1 signaling in cancer cell invasion reveal an essential role of the Rho-Rho kinase axis and tumor microenvironment

Topoisomerase II activities in AML blasts and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines

Oral idarubicin, dexamethasone and vincristine (VID) in the treatment of multiple myeloma

Functional P-gp expression in multiple myeloma patients at primary diagnosis and relapse or progressive disease

Topoisomerase II activities in AML blasts and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines

In Vitro Efficacy of Known P-Glycoprotein Modulators Compared to Droloxifene E and Z: Studies on a Human T-Cell Leukemia Cell Line and their Resistant Variants

Nuclear Topoisomerase II Activity Changes During HL-60 Leukemic Cell Differentiation: Alterations in Drug Sensitivity and pH Dependency

Designing a broad-spectrum integrative approach for cancer prevention and treatment

Uncoupling of EGFR-RAS signaling and nuclear localization of YBX1 in colorectal cancer

Aktive Filter

Suchergebnisse filtern